sacituzumab
gilead sciences,celsion
['trodelvy', ' ovation']
 but there was good news out of esmo - trodelvy s interim os data have gone up to 3 months. i won t give that a standing ovation, but we now have two more treatments with 8 months combined. and more adcs on the way. better to tolerate than chemo, too. 
“Even if I’m dying, until I actually die, I am still living” - Paul Kalanithi. “Participate in clinical trials for those behind us” - me. she/her